Hong Kong-listed pharma WuXi AppTec is investing $5 million in Creacion Ventures I as it joins over a dozen limited partners (LPs) to build a $200-million life science fund to tap investment opportunities in Greater China, North America and European Union (EU).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
